Munafa Stock Market Course + Intraday & FNO calls 
AST NEWS why is Asterias Biotherapeutics Inc. price falling or rising
AST NEWS reasons for why stock price of Asterias Biotherapeutics Inc. is falling or rising
AST Asterias Biotherapeutics is falling or rising technical reasons
Technical analysis forecast of Asterias Biotherapeutics Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Asterias Biotherapeutics AST at this time. Stock is rising and might rise more.
It appears as if Asterias Biotherapeutics AST gave a large move recently.
Stock of Asterias Biotherapeutics (AST) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Asterias Biotherapeutics is bullish for shortterm, and stock might move up till 1 or till 1. Use a stoploss of 0.91 and if this stock hits its stoploss, then it can fall down till 0.87
AST Asterias Biotherapeutics is falling or rising NEWS fundamental reasons
Bullion hits new peaks: Gold approaches Rs 1.39 lakh, silver surges past Rs 2.32 lakh. What’s ahead now? Gold and silver hit record highs as rate-cut hopes, weak dollar and geopolitical risks fuel strong investor demand. - NEWS as on 2025-12-26 indiatimes.com
Cabinet approves Delhi Metro Phase V: Rs 12,015 crore expansion to add 13 new stations, push network past 400 km Delhi Metro's Phase V (A) expansion, valued at ?12,015 crore, has been greenlit, promising 13 new stations across three corridors covering 16 kilometers. This significant development will extend the capital's rapid transit network beyond 400 kilometers wit - NEWS as on 2025-12-24 indiatimes.com
Comcast (CMCSA) Outpaces Stock Market Gains: What You Should Know Comcast (CMCSA) concluded the recent trading session at .78, signifying a +1.36% move from its prior day's close. - NEWS as on 2025-12-24 nasdaq.com
AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer (Revised) AstraZeneca's Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer. - NEWS as on 2025-12-23 nasdaq.com
Short-term JGB yields rise to record high after last week's BOJ rate hike ?Japanese government bonds fell further on Monday, sending short-term ?yields to a record high, following the central bank's interest rate hike last week. - NEWS as on 2025-12-22 indiatimes.com
Citi sets 12-month bitcoin forecast at 3,000 on rising adoption, regulatory easing Citigroup set its 12-month forecasts for bitcoin ?and ether at 3,000 ?and ,304, respectively, betting on regulatory easing and increased ?adoption. - NEWS as on 2025-12-19 indiatimes.com
Fast Capital, Smart Dilution: Why QIPs are the go-to route for listed companies Qualified Institutional Placements have emerged as a key fundraising route in India, enabling listed companies to raise capital quickly from institutional investors. QIPs signal strategic intent, balance-sheet strengthening and growth readiness, while offe - NEWS as on 2025-12-18 indiatimes.com
Micron earnings blow past expectations — and the stock is climbing - NEWS as on 2025-12-17 marketwatch.com
Rupee hits new record low, slips past 91-mark against US dollar. What does this mean for Indian stock market? The Indian rupee reached a new low against the US dollar on Tuesday. Foreign institutional investors are selling Indian assets. Uncertainty over a trade deal with the US is also impacting the currency. The rupee has seen significant depreciation recently. - NEWS as on 2025-12-16 indiatimes.com
Ranveer Singh-starrer 'Dhurandhar' storms past Rs 550 crore mark at worldwide box office Filmmaker Aditya Dhar's espionage drama 'Dhurandhar' has become a global box office sensation. The Ranveer Singh-starrer has collected Rs 552.70 crore worldwide in just 10 days. The film recorded the biggest Sunday ever for a Hindi movie on its second Sund - NEWS as on 2025-12-15 indiatimes.com
Equity mutual funds deliver upto 6% return last week. Check top 10 toppers Equity mutual funds recorded strong performance over the past week, with 565 out of 593 schemes delivering positive returns. International, commodities, sectoral, and thematic funds dominated the top performers, led by DSP World Mining Overseas Equity Omni - NEWS as on 2025-12-14 indiatimes.com
IndiGo Meltdown: India must have at least five airlines with 100 aircraft each to avoid such crises, says aviation minister India's Civil Aviation Minister K. Ram Mohan Naidu has highlighted the urgent need for at least five airlines, each with about 100 aircraft. This move aims to prevent future aviation crises and reduce passenger dependence on a few dominant carriers. The mi - NEWS as on 2025-12-11 indiatimes.com
Kaynes Tech selloff spills to Dixon Tech, Amber, PG Electroplast as shares fall up to 9% Shares of EMS companies Dixon, Amber, and PG Electroplast declined sharply on Wednesday, tracking the fall in Kaynes Technology and extending the sector’s recent weakness. Dixon led the slide, plunging over 9% intraday—its biggest drop since January—before - NEWS as on 2025-12-10 indiatimes.com
Brokerage takes down faulty article on PG Electroplast, conveys regrets HDFC Securities apologised to PG Electroplast after an article on its HDFC Sky platform was found to contain factual inaccuracies and misleading claims, prompting the brokerage to remove it and initiate an internal review following the company’s objections - NEWS as on 2025-12-09 indiatimes.com
More announcements and NEWS
AST Asterias Biotherapeutics Inc. current price & indicator signals
Recent prices of AST Asterias Biotherapeutics Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 07 Thu Mar 2019 | 0.95 | 0.90 to 0.95 | 0% | 1.27 times |
| 06 Wed Mar 2019 | 0.95 | 0.87 to 0.95 | 6.74% | 0.82 times |
| 05 Tue Mar 2019 | 0.89 | 0.85 to 0.89 | 2.3% | 1.5 times |
| 04 Mon Mar 2019 | 0.87 | 0.85 to 0.95 | -8.42% | 2.24 times |
| 01 Fri Mar 2019 | 0.95 | 0.91 to 0.97 | 4.4% | 0.77 times |
| 28 Thu Feb 2019 | 0.91 | 0.91 to 0.98 | -7.14% | 0.89 times |
| 27 Wed Feb 2019 | 0.98 | 0.95 to 0.98 | 1.03% | 0.47 times |
| 26 Tue Feb 2019 | 0.97 | 0.92 to 1.00 | 3.19% | 1.01 times |
| 25 Mon Feb 2019 | 0.94 | 0.91 to 0.99 | 1.08% | 1.32 times |
| 22 Fri Feb 2019 | 0.93 | 0.92 to 0.94 | 0% | 0.31 times |
| 21 Thu Feb 2019 | 0.93 | 0.92 to 0.95 | 1.09% | 0.68 times |
| 20 Wed Feb 2019 | 0.92 | 0.92 to 0.98 | -4.17% | 0.87 times |
Videos related to: AST NEWS why is Asterias Biotherapeutics Inc. price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- AMEX Screeners
- AMEX Daily Screener
- AMEX Weekly Screener
- AMEX Monthly Screener
- Support & Resistance
- AMEX Shares Near Support
- AMEX Shares Near Resistance
